Treatment Plan for Moderate Depression, Mild Anxiety, and Adjustment Disorder Secondary to Domestic Violence
Primary Recommendation
For this patient with moderate depression (PHQ-9=19), mild anxiety (GAD-7=8), and adjustment disorder secondary to domestic violence, initiate individual cognitive-behavioral therapy (CBT) as first-line treatment, with consideration for adding an SSRI (such as sertraline 50mg daily) given the moderate severity of depressive symptoms and limited immediate access to psychotherapy. 1, 2
Treatment Algorithm
Step 1: Prioritize Depression Treatment
- When depression and anxiety co-occur, prioritize treatment of depressive symptoms first, as this patient's PHQ-9 score of 19 indicates moderate depression while GAD-7 of 8 reflects only mild anxiety 2, 3
- The moderate severity of depression (PHQ-9=19) warrants more aggressive intervention than psychotherapy alone 1
Step 2: First-Line Psychotherapy
- Individual CBT is the most evidence-based psychological intervention for adjustment disorder, focusing on modifying cognition and behavior to reduce unpleasant feelings and improve social adjustment 1
- For moderate depressive symptoms, offer individual or group therapy with CBT, behavioral activation (BA), or psychosocial interventions with empirically supported components (relaxation, problem solving) 2
- The patient is already engaged with EAP counseling through [PROVIDER], which should be continued if possible post-employment cessation 1
Step 3: Pharmacotherapy Considerations
Given this patient's moderate depression severity and the plan includes psychiatrist referral, pharmacotherapy is appropriate as:
- Combination of psychotherapy and medication is recommended as first-line treatment for moderate to severe adjustment disorder 1
- Pharmacologic regimens may be offered for depression in patients without immediate access to first-line treatment, those expressing preference for pharmacotherapy, or those with severe symptoms 2
- SSRIs are the preferred pharmacological option for adjustment disorder with depressive features and comorbid anxiety due to favorable side effect profiles 1, 3, 4
Specific SSRI Recommendation: Sertraline
- Start sertraline 25mg daily for the first week, then increase to 50mg daily 5
- Sertraline is FDA-approved for major depressive disorder and has demonstrated efficacy in moderate depression 5
- Monitor for suicidal thoughts or actions, especially in the first few months of treatment or when dose is changed 5
- Avoid benzodiazepines for long-term management despite anxiety symptoms; they should only be used short-term if severe anxiety requires bridging while SSRI takes effect 1, 6
Step 4: Monitoring and Assessment Schedule
Regular assessment using standardized instruments is essential:
- Reassess with PHQ-9 and GAD-7 at 4 weeks and 8 weeks 2
- If pharmacologic treatment is used, assess symptom relief, side effects, adverse events, and patient satisfaction at 4 and 8 weeks 2
- Mental health professionals providing psychological treatment should assess treatment response at pretreatment, 4 weeks, 8 weeks, and end of treatment 2
Step 5: Treatment Adjustment Protocol
After 8 weeks, if little improvement despite good adherence:
- Adjust the regimen by adding a psychological or pharmacologic intervention to single treatment 2
- If using pharmacotherapy, change the medication 2
- If using group therapy, refer to individual therapy 2
- If symptoms are stable or worsening, re-evaluate the plan and revise 2
Addressing Comorbid Conditions
Adjustment Disorder Management
- Psychotherapy alone without medication is first-line for mild adjustment disorder, but this patient has moderate depression requiring combined approach 1
- The domestic violence history and recent life stressors (resignation, relocation, separation from children) are clear precipitants requiring trauma-informed care 1
- Incorporate family involvement when possible, though this patient has limited social support 1
Anxiety Component
- The mild anxiety (GAD-7=8) will likely improve with depression treatment 2, 3
- If anxiety symptoms persist or worsen, consider structured physical activity and exercise, or psychosocial interventions with relaxation and problem-solving components 2
Critical Safety Considerations
Suicide Risk Monitoring
- This patient reported previous thoughts of self-harm during 2nd counseling session 5
- Watch for new or sudden changes in mood, behavior, actions, thoughts, or feelings, especially when starting sertraline or changing doses 5
- Crisis helpline number has been appropriately provided 1
- Instruct patient to contact crisis helpline if feeling unwell and not wait for scheduled appointments if deteriorating 5
Medical Workup
- Complete planned blood tests (FBC, iron studies, TFTs) to rule out iron deficiency and thyroid dysfunction contributing to symptoms 2
- Weight loss and sleep disturbance may have medical causes requiring exclusion 2
Psychosocial Support Interventions
Essential components already initiated:
- Wellness advisor referral with phone appointment booked 1
- Psychiatrist referral for medication assessment 1
- Follow-up appointment scheduled 1
- Medical certificate provided for [ORGANIZATION] 1
Additional recommendations:
- Provide culturally informed and linguistically appropriate information about depression commonality, symptoms, signs of worsening, and when to contact medical team 2
- Address limited social support (only 1 close [RELATIVE], no friends) through wellness advisor and consider support groups 2, 1
- Promote patient independence and involvement in decision-making regarding medical care 1
Common Pitfalls to Avoid
- Do not treat anxiety as primary condition when moderate depression is present; prioritize depression treatment 2, 3
- Avoid long-term benzodiazepine use despite anxiety symptoms; use SSRIs for both conditions 1, 6
- Do not discontinue treatment prematurely before adequate coping skills are developed 1
- Do not ignore the domestic violence context; this requires trauma-informed approach and safety assessment 1
- Avoid monotherapy with psychotherapy alone given moderate depression severity; combination approach is indicated 1
- Do not neglect regular monitoring; use standardized instruments (PHQ-9, GAD-7) at 4 and 8 weeks 2